Explore evidence

Gold tier: mechanically validated evidence, with its primary source.

7 evidence items · page 1 / 1

2.3 odds_ratioThe combined effect of diabetes mellitus on tuberculosis risk was an odds ratio of 2.3 with a 95% confidence interval of [2.0–2.7].

Cameroundiabète (non précisé) · tuberculosepublished 2021PloS oneeurope_pmcdocument of 10 observationsDOI 10.1371/journal.pone.0261246

2 odds_ratioThe odds ratio for tuberculosis risk in cohort studies with diabetes mellitus was 2.0 with a 95% confidence interval of [1.5–2.4].

Cameroundiabète (non précisé) · tuberculosepublished 2021PloS oneeurope_pmcdocument of 10 observationsDOI 10.1371/journal.pone.0261246

2.5 odds_ratioThe odds ratio for tuberculosis risk in cross-sectional studies with diabetes mellitus was 2.5 with a 95% confidence interval of [1.8–3.5].

Cameroundiabète (non précisé) · tuberculosepublished 2021PloS oneeurope_pmcdocument of 10 observationsDOI 10.1371/journal.pone.0261246

2.4 odds_ratioThe odds ratio for tuberculosis risk in case control studies with diabetes mellitus was 2.4 with a 95% confidence interval of [2.0–2.9].

Cameroundiabète (non précisé) · tuberculosepublished 2021PloS oneeurope_pmcdocument of 10 observationsDOI 10.1371/journal.pone.0261246

503,760 casesThe systematic review included 503,760 cases (diabetes mellitus or tuberculosis patients).

Cameroundiabète (non précisé) · tuberculosepublished 2021PloS oneeurope_pmcdocument of 10 observationsDOI 10.1371/journal.pone.0261246

0.4 odds_ratioThe slow acetylation variant NAT2*5 was associated with a decreased risk of drug-induced hepatotoxicity (OR: 0.4; 95%CI: 0.17–0.96; p = 0.038) among patients treated for tuberculosis in Cameroon.

Camerountuberculoseobserved 2018-2019published 2024BMC infectious diseaseseurope_pmcdocument of 4 observations

4.2 odds_ratioThe NAT2*6 variant was associated with an increased risk of drug-induced hepatotoxicity (OR: 4.2; 95%CI: 1.1–15.2; p = 0.017) among patients treated for tuberculosis in Cameroon.

Camerountuberculoseobserved 2018-2019published 2024BMC infectious diseaseseurope_pmcdocument of 4 observations

Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.